These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 433370)

  • 21. [Significance of the iron and copper content of the liver for the differential diagnosis of chronic liver diseases].
    Schwabe U; Friedrich K
    Z Gastroenterol; 1990 Jul; 28(7):353-7. PubMed ID: 2238766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of spontaneous hepatocellular carcinoma in Long-Evans cinnamon rats with hereditary hepatitis by the administration of D-penicillamine.
    Jong-Hon K; Togashi Y; Kasai H; Hosokawa M; Takeichi N
    Hepatology; 1993 Sep; 18(3):614-20. PubMed ID: 8395459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Wilson's disease. A histological review of 7 patients and the value of histological copper positivity in relation to other hepatopathies].
    Blasco A; Domínguez P; Colina F; Castellano G
    Med Clin (Barc); 1992 Feb; 98(6):207-11. PubMed ID: 1373211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Wilson's disease and secondary copper hemochromatoses in hematological practice].
    Vorob'ev AI; Lukina EA; Sysoeva EP; Levina AA; Solov'eva TI
    Ter Arkh; 2004; 76(7):55-9. PubMed ID: 15379129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease.
    Farinati F; Cardin R; D'inca R; Naccarato R; Sturniolo GC
    J Lab Clin Med; 2003 Jun; 141(6):372-7. PubMed ID: 12819634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on levels of penicillamine-induced cupriuresis in heterozygotes of Wilson's disease.
    Tu JB; Blackwell RQ
    Metabolism; 1967 Jun; 16(6):507-13. PubMed ID: 6028804
    [No Abstract]   [Full Text] [Related]  

  • 27. [Wilson's disease: physiopathology, therapeutic approach and case report].
    Gallo V; Riva P; Sidoli L; Bisbocci D
    Minerva Gastroenterol Dietol; 1994 Dec; 40(4):197-201. PubMed ID: 7849148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [D-penicillamine in various diseases in childhood (author's transl)].
    Weingärtner L
    Med Klin; 1979 Jun; 74(26):1038-42. PubMed ID: 460039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic copper in primary biliary cirrhosis: biliary excretion and response to penicillamine treatment.
    Salaspuro MP; Pikkarainen P; Sipponen P; Vuori E; Miettinen TA
    Gut; 1981 Nov; 22(11):901-6. PubMed ID: 7308845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of oxidant stress in Wilson's disease and non-Wilsonian chronic liver disease in childhood.
    Dalgiç B; Sönmez N; Biberoğlu G; Hasanoğlu A; Erbaş D
    Turk J Gastroenterol; 2005 Mar; 16(1):7-11. PubMed ID: 16252181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Abnormal hepatic copper accumulation and its significance in LEC rats developing spontaneous hepatitis and hepatoma].
    Li Y
    Hokkaido Igaku Zasshi; 1991 Sep; 66(5):658-64. PubMed ID: 1959841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Wilson's disease: a review apropos of a clinical experience in 16 patients].
    Miranda M; Brinck P; Roessler JL; Troncoso Sch M; González M; Alarcón T; Villagra R
    Rev Med Chil; 1995 Sep; 123(9):1098-107. PubMed ID: 8728733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver transplantation for Wilson's disease.
    Sevmis S; Karakayali H; Aliosmanoglu I; Yilmaz U; Ozcay F; Torgay A; Arslan G; Haberal M
    Transplant Proc; 2008; 40(1):228-30. PubMed ID: 18261593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Oral zinc in Wilson disease--an alternative to D-penicillamine].
    Ramadori G; Keidl E; Hütteroth T; Dormeyer HH; Manns M; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1985 Jan; 23(1):25-9. PubMed ID: 4060799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of D-penicillamine on liver fibrosis and inflammation in Wilson disease.
    Kazemi K; Geramizadeh B; Nikeghbalian S; Salahi H; Bahador A; Reza Nejatollahi SM; Dehghani SM; Dehghani M; Kakaei F; Malek-Hosseini SA
    Exp Clin Transplant; 2008 Dec; 6(4):261-3. PubMed ID: 19338486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Wilson's disease in personal material--disturbances in hemostasis].
    Jabłońska-Kaszewska I; Dabrowska E; Oziebłowski A
    Pol Tyg Lek; 1995 Sep; 50(36-39):79-81. PubMed ID: 8650042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis and management of Wilson's disease: results of a single center experience.
    Medici V; Trevisan CP; D'Incà R; Barollo M; Zancan L; Fagiuoli S; Martines D; Irato P; Sturniolo GC
    J Clin Gastroenterol; 2006; 40(10):936-41. PubMed ID: 17063115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iron accumulation in the liver of male patients with Wilson's disease.
    Shiono Y; Wakusawa S; Hayashi H; Takikawa T; Yano M; Okada T; Mabuchi H; Kono S; Miyajima H
    Am J Gastroenterol; 2001 Nov; 96(11):3147-51. PubMed ID: 11721763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The development of cirrhosis in Wilson's disease.
    Sternlieb I
    Clin Gastroenterol; 1975 May; 4(2):367-79. PubMed ID: 1092490
    [No Abstract]   [Full Text] [Related]  

  • 40. [Urinary copper excretion from rats following administration of aliphatic and alicyclic polyamines (author's transl)].
    Harders H; Armah B; Cohnen E; Führ J; Heinz N; Schröder HF
    Arzneimittelforschung; 1980; 30(2):254-8. PubMed ID: 7378100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.